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Abstract
Background and Aim: The immunocompromised condition is considered a defect in the immune system. This condition 
tends to increase the risk of oral candidiasis, due to the inability of the immune system to eliminate the adhesion of Candida 
albicans and leads to systemic candidiasis with a mortality rate of 60%. Green tea (Camellia sinensis) contains potential 
antioxidant and immunomodulatory which acts as anticancer, antifungal, and antivirus agent. The aim of this study was 
to invent herbal-based medicine, which acts as an immunomodulator and antifungal agent to treat fungal infection in 
immunocompromised patients.
Materials and Methods: Thirty-five immunocompromised Wistar rats induced with C. albicans were divided into 7 groups 
(n=5): Control group (C+); treated for 4 days with green tea extract 1.25% (GT 4), epigallocatechin gallate (EGCG) 1% 
(EGCG 4), EGC 1% (EGC 4); and treated for 7 days with green tea extract 1.25% (GT 7), EGCG 1% (EGCG 7), and EGC 
1% (EGC 7). Tongue tissue was collected and analyzed with immunohistochemistry staining using monoclonal antibody; 
interleukin (IL)-17A, IL-8, and human beta-defensin 2 (HBD)-2. Data were analyzed using analysis of variance test and 
Tukey honest significant differences test.
Results: The expression of IL-17A, IL-8, and HBD-2 was significantly increased (p=0.000) after green tea extract 
administration in 7 days, whereas in 7 days, the expression of IL-8, IL-17A, and HBD-2 after EGCG and EGC administration 
did not give a significant result (p>0.005).
Conclusion: Within the limits of this study, green tea extract has the ability as an immunomodulatory agent in an 
immunocompromised patient infected by C. albicans through expression augmentation of IL-8, IL-17A, and HBD-2 
compared to EGCG and EGC.
Keywords: epigallocatechin gallate, epigallocatechin, green tea extract, immunocompromised, oral candidiasis.
Introduction
The immune system is an essential mechanism 
to against microorganism and its toxins. The defect 
in the immune system could lead to an immunocom-
promised condition that put patients at high risk of 
various infections of fungal, viral, and bacterial infec-
tions [1]. One of the most common infection is fungal 
infection, oral candidiasis, which could lead to sys-
temic candidiasis with a mortality rate of 60% [1,2]. 
Candida albicans is part of the indigenous microbial 
flora in humans and can be found in the oral cavity, 
and is unique among opportunistic pathogens because 
it is part of the normal microbial flora of the host [1,3]. 
C. albicans has been shown to play an important role 
in oral candidiasis, denture stomatitis, and severe peri-
odontitis. In immunocompromised patients, mucosal 
immunity is not able to eliminate the adhesion of 
C. albicans. The prevalence of oral candidiasis tends 
to increase along with immunocompromised patients, 
such as human immunodeficiency virus (HIV), dia-
betes mellitus, iatrogenic infections, and cancer [4]. 
The condition causes impaired phagocytosis effect of 
polymorphonuclear cells, and macrophages decrease 
the quality and quantity of cytokines [5]. C. albicans 
infection triggers differentiation of T helper (Th) cell 
into Th17 to produce Interleukin 17 (IL-17) through 
activation IL-23 that was produced by dendritic cells. 
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IL-17A plays an important role in mobilization and 
fungicidal activity of neutrophil [5,6]. In addition, 
activation of IL-17A through receptor IL-17R in epi-
thelial induce the release of human beta-defensin 2 
(HBD-2). HBD-2 is part of innate immunity system 
that plays a role in recruitment and activation of neu-
trophil to phagocyte against C. albicans [7].
The resistance to antifungal agents tends to 
increase nowadays and causes failure of treatment. 
Therefore, innovation is needed to enhance the effec-
tivity of antifungal agents. The common anti-fungal 
agents gradually become more unaffordable for some 
Indonesians. Therefore, it is required to seek a solu-
tion to treat oral candidiasis in immunocompromised 
patients properly.
Current researches which are supported by 
Ministry of Technology and Higher Education tend to 
use more natural ingredients. Herbal based medicines 
could be the proper solution to treat some diseases. 
In addition, herbal medicines are abundantly provided 
in nature, affordable, have a low toxicity level, and 
are recognized safe by Food and Drug Administration 
(FDA) [8]. Catechin that contained in green tea could 
have higher bioavailability when absorbed orally.
One of the natural ingredients that are widely 
consumed by Indonesians is Camellia sinensis (green 
tea), which is known to act as a potent antioxidant. It 
contains catechins that consist of epicatechin (EC), 
epigallocatechin (EGC), EC gallate, and EGC gallate 
(EGCG). It is reported that catechin in green tea has the 
ability as antioxidant, anticancer, antifungal, and anti-
virus [9]. EGCG and EGC act as an immunomodulator 
by influencing the proliferation of lymphocyte T and 
cytokines production. Green tea extract enhances lym-
phoblast to induce the production of lymphocytes, 
while EGCG stimulates the production of IL-1α, 
IL-1β, monocytes, and lymphocytes [10].
The EGCG and EGC administered orally could 
suppress inflammation, inhibit proliferation and 
pro-inflammation cytokines, as well as, inhibit the 
activation of NF-кB [11]. This condition leads to 
lower level of IL-8 which plays as chemoattractant 
and neutrophil recruitment. The active component is 
responsible for biological effects such as immuno-
modulator, anti-tumor activity, and antimicrobial [12].
It is possible that green tea possesses 
immunomodulatory effect against oral candidiasis 
in immunocompromised patients. However, further 
investigation is needed to study the immunomodula-
tory effect of green tea extract, EGCG, EGC through 
increasing expression of IL-8, IL-17A, and HBD-2. 
This aim of this study was to develop natural based 
immunomodulator and anti-fungal agent to treat fun-
gal infection in immunocompromised patients.
Materials and Methods
Ethical approval
This study has been approved by the Commission 
of Ethical Clearance, Faculty of Dental Medicine, 
Universitas Airlangga, Surabaya, Indonesia (No. 306/
HRECC.FODM/XXI/2017).
Animals
The research was post-test only control group 
design using Wistar rats as an animal model. The cri-
teria of rats were healthy, 3 months old, and weighing 
around 250 g. This study using 35 immunocompro-
mised Wistar rats induced with C. albicans, which 
are divided into 7 groups (n=5): Control group (C+); 
treated with green tea extract concentration 1.25% for 
4 (GT 4) and 7 (GT 7) days; EGCG 1% for 4 (EGCG 
4) and 7 (EGCG 7) days; and treated EGC 1% for 4 
(EGC 4) and 7 (EGC 7) days.
Experimental design
This study was conducted in Integrated 
Research and Testing Laboratory Biochemistry 
Faculty of Medicine, Universitas Airlangga. 
Immunocompromised condition was induced 
by Dexamethasone 0.8 mg/kg and Tetracycline 
12 mg/kg intraperitoneally for 7 days. Blood serums 
were collected on day 1 and 7 to measure the immu-
nocompromised condition through a blood test. The 
immunocompromised rats were then induced with 
C. albicans, by inoculating 0.1 mL saline suspension 
which contains 3×10 8 C. albicans to tongue tissue 
using cotton rolls in all groups for 6 times in day 7-12. 
Treatment groups were treated with green tea extract, 
EGCG and EGC until 16 and 19 days, respectively, 
based on its group treatment.
Preparation of green tea extract
Two and half gram of dried green tea leaf was 
mixed into 200 mL of boiling distilled water for 
30 min. After being rested and filtered, the extract was 
freeze-dried to preserve the component substances 
green tea extract with a concentration of 1.25% was 
made by mixed 12.5 mg of dried green tea extract with 
100 mL of distilled water for 30 min. It was followed 
by filtering the extract.
Preparation of EGCG and EGC extract
The EGC and EGC powder was obtained from 
Xi’an Rongsheng Biotechnology Co., Ltd, Xi’an, 
PRC. There were 2.5 g of EGCG and EGC powder in 
250 mL sterilized distilled water needed to make 1% 
EGCG and EGC solution. The solution was double 
filtered 30 min after mixture to gain clear EGCG and 
EGC solution.
Immunohistochemistry assay (IHC)
The rats were decapitated using a combination of 
Ketamine and Xylazine (100 mg/kg and 10 mg kg/BB) 
intramuscular injection. C+ group was terminated on 
day 13; while GT 4, EGC 4, and EGCG 4 groups were 
terminated on day 16; and green tea 7, EGCG 7, and 
EGC 7 were terminated on day 19. Tongue tissues 
were collected and analyzed using IHC staining using 
monoclonal antibody of IL-17A, IL-8, and HBD-2 
from Santa Cruz Biotech (Santa Cruz Biotechnology 
Inc., Dallas, Texas, USA) and examined under 
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Olympus digital microscope (Olympus Co., Tokyo, 
Japan) at 400× magnification.
Statistical analysis
The data were analyzed using SPSS software ver-
sion 10.05 (SPSS Inc., Chicago, USA) with ANOVA 
and post hoc Tukey honest significant differences 
(HSD) test.
Results
The IHC results of IL-8 expression are showed in 
Figure-1. Mean of each group for IL-8 expression was 
shown in Figure-2. ANOVA results showed that the 
expression of IL-8 was significantly different for each 
group (p=0.000). Tukey HSD test results in 4 days 
showed there was significant difference expression 
between GT 4 group compared to EGCG4 (p=0.011) 
and EGC4 (p=0.000) groups. However, there was 
no significant difference of IL-8 expression between 
EGCG 4 and EGC 4 groups (p=0.495). The expres-
sion of IL-8 in day 7 was higher than in day 4. Tukey 
HSD test result showed greater expression of IL-8 in 
GT 7 group compared to EGCG 7(p=0.000) and EGC 
7 (p=0.000) groups. The expression of IL-8 between 
EGCG 7 and EGC 7 groups did not show a significant 
difference (p=0.394).
The expression of IL-17A is shown in Figure-3, 
and the mean is shown in Figure-4. The expression 
of IL-17A was significantly different in each group 
(p=0.000). Tukey HSD test results in 4 days showed 
there was a significant difference between GT 4 group 
compared to EGCG 4 (p=0.010) and EGC4 (p=0.000) 
groups. Meanwhile, the comparison of IL-17A 
expression between EGCG 4 and EGC 4 did not show 
a significant difference (p=0.076). The expression of 
IL-17A on day 7 is higher than on day 4. HSD test 
result showed higher expression of IL-17A in GT 7 
group compared to EGCG 7 (p=0.000) and EGC 7 
(p=0.000) groups. The expression of IL-17A between 
EGCG 7 and EGC 7 groups did not show a significant 
difference (p=0.110).
The expression of HBD-2 is shown in Figure-5, 
while the means are shown in Figure-6. The expres-
sion of HBD-2 was significantly different for each 
group (p=0.000. Tukey HSD test result showed no 
significant difference in HBD-2 expression in GT 
4 group compared to EGCG 4 group (p=0.080) but 
showed a significant difference if compared to EGC 4 
group (p=0.023). The expression of HBD-2 between 
EGCG 4 and EGC4 groups did not show any sig-
nificant difference (p=0.998). The expressions of 
HBD-2 in day 7 are greater than on day 4. Tukey 
HSD test result showed that the expression of HBD-2 
in GT 7 group was significantly different compared 
to EGCG 7 (p=0.000) and EGC 7 (p=0.001) groups. 
Meanwhile, the expression of HBD-2 between EGCG 
7 and EGC 7 groups did not show a significant differ-
ence (p=0.998).
Discussion
The current management of oral candidiasis 
is not effective enough, especially for immunocom-
promised individuals, due to high risk of recurrence. 
Therefore, adjunctive therapy is needed to get a better 
result. Recently, approximately 80% of antimicrobial, 
cardiovascular, immunosuppressive, and anticancer 
drugs are of plant origin. It is widely accepted that 
more than 80% of drug substances are either directly 
derived from natural products or developed from a 
natural compound [13]. One of the plants that have 
a therapeutic effect is green tea (Camellia Sinensis). 
Green tea extract is known to have anti-oxidant and 
antifungal properties [14].
Prevalence of oral candidiasis tends to increase 
each year as increasing number of the immunocom-
promised patient due to diabetes mellitus, prolonged 
consumption immunosuppressant and antibiotic, 
transplant organ recipient, cancer survivor, and patient 
with HIV/AIDS [15]. Prolonged and irrational usage 
of anti-fungal (azole) is believed to contribute to the 
higher prevalence of oral candidiasis, which leads 
Figure-2: The mean of interleukin-8 expression level after 
treated with green tea extract, epigallocatechin (EGC) 
gallate, and EGC.
Figure-1: Immunohistochemistry of interleukin-8 
expression (black arrow) in tongue tissue (400×) in 
the group which treated with green tea extract (a), 
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to treatment failure [16]. Therefore, innovation to 
enhance anti-fungal effectivity is needed. In immu-
nocompetent patients, every microorganism including 
fungi is controlled by the immune response, whether 
specific or non-specific. The immune system of immu-
nocompromised patient fails to eliminate the adhesion 
of Candida that leads to oral candidiasis [6].
Several antifungal agents, nystatin, and azole are 
reported to be resistant to oral candidiasis. Meanwhile, 
improper treatment of oral candidiasis may lead to sys-
temic infection of Candida that increases mortality rate 
to 60% [17]. Green tea extract which contains EGCG 
and EGC is considered as an herbal-based therapy for 
oral candidiasis. Green tea extract is generally recog-
nized as safe by the FDA Safety of the USA [8], because 
of green tea that is traditionally consumed as food relies 
on that history of food use as evidence of safety.
This study showed that IL-8 is increased on day 4 
and 7 after treated green tea extract. Green tea extract 
showed higher IL-8 expression compare to EGCG and 
EGC due to green tea extract contains various active 
components which synergistically increase IL-8 
expression. IL-8 is important due to chemo-attractant 
properties which recruit neutrophils for phagocytosis 
to inhibit C. albicans colony formation. A previous 
study by Steubesand et al. [18] showed oral admin-
istration of EGCG and EGC could inhibit the synthe-
sis of pro-inflammation cytokines and the activation 
of NF-κB which leads to decreasing IL-8 expression 
and increasing HBD-2. Various components contain 
in green tea extract work synergistically to enhance 
the expression of IL-17A and IL-8 which play as a 
chemoattractant to release HBD-2.
The expression of IL-17A is shown in Figure-4 
after treated with green tea extract was significantly dif-
ferent in each group (p=0.000). Meanwhile, the com-
parison of IL-17A expression between the group treated 
with EGCG and EGC did not show a significant differ-
ence (p=0.076) in day-7 is higher than on day-4. There 
is the IL-17A play vital role in mobilization and activity 
of neutrophils against infection, and it will be expressed 
by the activity of Th17 through RORγt and increases the 
number of neutrophils to inhibit oral candidiasis, even in 
immunocompromised patients [19,20]. Green tea extract 
contains flavonoids which have an immunomodulatory 
effect, thus enhance IL-2 production which activates the 
proliferation and differentiation of T cells differentiate 
into Th1 and Th2, Th1 cells secrete various cytokines 
Interferon gamma (IFN-γ) to activate macrophages 
[21]. Flavonoid contained in green tea extract enhances 
proliferation of lymphocytes could affect CD4+ cells to 
activate Th17 and produces IL-17A [22]. It is followed 
by epithelial induction through IL-17R, which activates 
the synthesis of HBD-2, IL-8, and G-CSF. Deficiency 
of IL-17A led to a neutrophil deficiency which increases 
the risk of systemic C. albicans infection.
The non-specific immune response is triggered 
as α-mannans binds to C. albicans cell wall. The 
binding stimulates specific immune response through 
Th17. The activity of Th17 cells through inducing 
Treg will reduce expression of Dectin-2 in C. albi-
cans [23]. These conditions stimulate the expression 
of various markers such as RORγt, IL-17A, and HBD-
2, as well as the number of neutrophils. A sufficient 
number of C. albicans might be increased and initiate 
oral candidiasis.
Green tea extract, EGC, and EGCG inhibit 
Candida biofilm formation and preformed biofilm. 
Higher EGCG concentration is reported to be substan-
tial for in vivo activity of C. albicans proteasome chy-
motrypsin-like. Proteasome activities disturb cellular 
metabolism and yeast structure [15]. In C. albicans 
infection, macrophages release various pro-inflam-
mation cytokines supported by IL-23 such as IL-17A, 
IL-21, and IL-22, and would trigger differentiation 
of Th into Th1, Th2, and Th17. IL-17A is the most 
prominent cytokines released by Th17 that was acti-
vated by IL-23. It is beneficial to trigger epithelial to 
secrete antimicrobial peptides and recruit neutrophils 
for phagocytosis, C. albicans in particular [10,12]. In 
certain condition, there would be declined secretion of 
IL-17 due to such mechanism by C. albicans to avoid 
Figure-4: Interleukin-17A expression level after treated 
with green tea extract, epigallocatechin (EGC) gallate, and 
EGC.
Figure-3: Immunohistochemistry of interleukin-17A 
expression (Black arrow) in tongue tissue (400×) of the 
group with green tea extract (a), epigallocatechin (EGC) 
gallate (b), EGC (c) on day 7.
c
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the host immune response.
HBD-2 expressions are higher in green tea extract 
group compared to EGC and EGCG. Higher expres-
sion HBD-2 in green tea extract group due to its abil-
ity to activate HBD-2 release as effector molecules in 
oral mucosal innate immunity. HBD-2 is part of muco-
sal primary defense mechanism against C. albicans 
through several mechanisms in the cell membrane, such 
as binding ions Ca2+ and Mg2+ [24]; consequently, 
there would be ion and peptide exchange that interfere 
the stability of C. albicans membrane. Instability of 
membrane leakage would lead to apoptosis of C. albi-
cans. This shows that various components contained 
in green tea extract work synergistically and simulta-
neously to increase IL-8 and IL-17A expressions. Lack 
of HBD-2 leads to reduce recruitment and activation of 
neutrophils and affects its phagocytic ability against C. 
albicans. Miramón et al. [25] stated that oral candidi-
asis can be cured in immunocompromised individuals. 
Decreasing number of HBD-2 stimulates reduce the 
activity and recruitment of neutrophil moreover lower 
phagocytosis activity against C. albicans.
Conclusion
The expressions of IL-17A, IL-8, and HBD-2 are 
higher after treated with green tea extract, compared 
to treatment with EGC and EGCG. The results show 
that green tea extract gives better immunomodulatory 
effect, compared to EGC and EGCG. It is concluded 
that green tea extracts possess immunomodulatory 
effect against C. albicans infection in immunocom-
promised patients by increasing the expression of 
IL-8, IL-17A, and HBD-2.
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